Evidence map›Paper›PMID 38413781›Full record

ReviewNature protocols2024

High-throughput fabrication of antimicrobial phage microgels and example applications in food decontamination.

Lei Tian, Kyle Jackson, Leon He, Shadman Khan, Mathura Thirugnanasampanthar, Mellissa Gomez, Fereshteh Bayat, Tohid F Didar, Zeinab Hosseinidoust

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Micro- and Nano-Bots for Infection Control.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lei TianDepartment of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0003-1184-1027
Kyle JacksonDepartment of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.
Leon HeDepartment of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-3755-4053
Shadman KhanSchool of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada.
Mathura ThirugnanasampantharDepartment of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.
Mellissa GomezDepartment of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.
Fereshteh BayatSchool of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-8868-1650
Tohid F DidarSchool of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada. didar@mcmaster.ca.
Zeinab HosseinidoustDepartment of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada. doust@mcmaster.ca.ORCID 0000-0001-9261-7611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineered by nature, biological entities are exceptional building blocks for biomaterials. These entities can impart enhanced functionalities on the final material that are otherwise unattainable. However, preserving the bioactive functionalities of these building blocks during the material fabrication process remains a challenge. We describe a high-throughput protocol for the bottom-up self-assembly of highly concentrated phages into microgels while preserving and amplifying their inherent antimicrobial activity and biofunctionality. Each microgel is comprised of half a million cross-linked phages as the sole structural component, self-organized in aligned bundles. We discuss common pitfalls in the preparation procedure and describe optimization processes to ensure the preservation of the biofunctionality of the phage building blocks. This protocol enables the production of an antimicrobial spray containing the manufactured phage microgels, loaded with potent virulent phages that effectively reduced high loads of multidrug-resistant Escherichia coli O157:H7 on red meat and fresh produce. Compared with other microgel preparation methods, our protocol is particularly well suited to biological materials because it is free of organic solvents and heat. Bench-scale preparation of base materials, namely microporous films (the template for casting microgels) and pure concentrated phage suspension, requires 3.5 h and 5 d, respectively. A single production run, that yields over 1,750,000 microgels, ranges from 2 h to 2 d depending on the rate of cross-linking chemistry. We expect that this platform will address bottlenecks associated with shelf-stability, preservation and delivery of phage for antimicrobial applications, expanding the use of phage for prevention and control of bacterial infections and contaminants.

Indexed as

BacteriophagesMicrogelsAnti-Infective AgentsDecontaminationEscherichia coli O157Food MicrobiologyAnti-Infective AgentsMicrogels

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.